New Technology– category –
-
Sustainable PLA/PCL Nanocomposite Achieves 309% Impact Strength Boost and Enhanced EMI Shielding
MDPI Switzerland Overview A new sustainable poly(lactic acid) (PLA)/poly(ε-caprolactone) (PCL) blend nanocomposite, reinforced with multi-walled carbon nanotubes (MWCNT) and graphene nanoplatelets, has been developed. This material boast... -
Nanoparticle Additives Revolutionize Thermal Management in Electronics Adhesives
PatSnap Eureka Unknown Overview As electronic devices rapidly miniaturize, enhancing adhesive thermal conductivity is crucial for sustaining performance and reliability. Integrating thermally conductive nanoparticles (e.g., carbon nanotu... -
Fluorine-Rich Carbon Quantum Dots Set New Efficiency Benchmarks for CO2-to-Methane Conversion
ResearchGate Unknown Overview Researchers have developed fluorine-rich carbon quantum dots (F1-CQDs) with up to 28.8 at.% fluorine, achieving exceptional performance in the selective electroreduction of CO2 to CH4. This catalyst demonstr... -
Precision Oncology Unleashed: Tumor-Specific Promoters and Nanocarriers Drive Next-Gen Gene Therapy, LNP-Based mRNA/siRNA Therapies Paving the Way
MDPI Switzerland Overview Precision cancer gene therapy is being transformed by the integration of tumor-specific promoters and nanodelivery systems, significantly enhancing therapeutic specificity. A range of nanocarriers, including LNP... -
Unlocking Next-Gen Wearables: Nanocomposites Enhance Chip Embedding for Extreme Environments
PatSnap Eureka Unknown Overview Novel polymer-based nanocomposites are revolutionizing wearable sensor chip embedding by significantly enhancing mechanical, thermal, and barrier properties, paving the way for advanced applications in aer... -
Multi-Walled Carbon Nanotubes Supercharge Li-ion Batteries: 3-10x Performance Boost at Competitive Costs
Cheap Tubes USA Overview Carbon Nanotubes (CNTs) are emerging as transformative conductive additives for lithium-ion batteries, delivering 3-10 times the performance enhancement of traditional carbon black with significantly reduced mate... -
FDA Issues New Draft Guidance to Accelerate Cell and Gene Therapy Development: Promoting Efficiency Through Prior Knowledge Utilization
FDA Press Announcements USA Overview The FDA announced new draft guidance on June 2, 2026, aimed at accelerating the development of cell and gene therapies. This guidance encourages sponsors to effectively leverage 'prior knowledge,' par... -
CRISPR Gene Editing Utilized: First Leishmaniasis Vaccine Receives FDA IND Approval, Advancing to Phase 1 Clinical Trial
Ohio State News USA Overview The first leishmaniasis vaccine, developed by researchers at Ohio State University, is set to begin a Phase 1 clinical trial after receiving Investigational New Drug (IND) approval from the FDA. This innovati... -
Fate Therapeutics’ iPSC-Derived CAR T Therapy FT836 Shows Tumor Reduction and Favorable Safety Profile in KRASwt Colorectal Cancer Phase 1 Data at ASCO
GlobeNewswire (Fate Therapeutics Press Release) USA Overview Fate Therapeutics presented preliminary Phase 1 clinical data for its iPSC-derived, off-the-shelf CAR T-cell therapy, FT836, at the 2026 American Society of Clinical Oncology (... -
Tempus AI and Roswell Park Unveil Groundbreaking AI Algorithms for Pancreatic Cancer and Metastatic RCC at ASCO 2026
Tempus 他 USA Overview At the 2026 ASCO Annual Meeting, Tempus AI and Roswell Park Comprehensive Cancer Center announced significant advancements in AI-driven oncology, showcasing novel algorithms designed to revolutionize cancer diagnos...
